BiotechTube

Cipepofol

ApprovedRecruiting
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Anesthesia

Conditions

Anesthesia

Trial Timeline

Jan 6, 2025 โ†’ May 30, 2025

NCT ID
NCT06740201

About Cipepofol

Cipepofol is a approved stage product being developed by Haisco Pharmaceutical Group for Anesthesia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06740201. Target conditions include Anesthesia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT06740201ApprovedRecruiting

Competing Products

20 competing products in Anesthesia

See all competitors
ProductCompanyStageHype Score
Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofolEisaiApproved
85
arm 1 + LUSEDRA + Propofol (arm 3)EisaiPhase 1
33
Remimazolam Tosilate for InjectionJiangsu Hengrui MedicinePre-clinical
23
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
77
Remimazolam TosylateJiangsu Hengrui MedicinePhase 1
33
HR020602 injection + fentanyl injection ๏ผ› remifentanil injectionJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 2
52
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
52
Ropivacaine + BupivacaineAstraZenecaPhase 3
77
SugammadexMerckPhase 2
52
SugammadexMerckPhase 2
52
Sugammadex + neostigmineMerckPhase 3
77
Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
77
Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
77
Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
77
Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3
77
Sugammadex + RocuroniumMerckPhase 3
77
Sugammadex + NeostigmineMerckPhase 3
77
sugammadexMerckPhase 3
77
Sugammadex + Succinylcholine + RocuroniumMerckPhase 3
77

Other Products from Haisco Pharmaceutical Group

Crisugabalin + PlaceboApproved
82
Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDApproved
82
Cyclopofol + PropofolApproved
82
Ciprofol + PropofolApproved
82
Acetyllevocarnitine Hydrochloride Tablets + PlaceboPhase 3
74